Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning

Free Radical Research

Volumn 31, Issue 2, 1999, Pages 103-112

  He, Y ^a   Lee, T ^a   Leong, S K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

6 hydroxydopamine; Dopaminergic cell death; Ferritin; Iron; Parkinson's disease; Substantia nigra; Transferrin

Indexed keywords

DOPAMINE; FERRITIN; IRON; OXIDOPAMINE; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; MALE; MICROGLIA; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; TEMPORAL CORTEX;

ANIMALS; CELL DEATH; DOPAMINE; FERRITINS; IMMUNOHISTOCHEMISTRY; IRON; KINETICS; MALE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TRANSFERRIN; TYROSINE 3-MONOOXYGENASE;

EID: 0032870588     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769900301611     Document Type: Article

References (45)

1. B. Halliwell (1992). Reactive oxygen species and the central nervous system. Journal of Neurochemistry, 59, 1609-1623.
2. D.T. Dexter, C.J. Cater, F.R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner and C.D. Marsden (1989). Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry, 52, 381-389.
3. A.J. Dwork, E.A. Schon and J. Herbert (1988). Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience, 27, 333-345.
4. M. Gerlach and P. Riederer (1993). The pathophysiological basis of Parkinson's disease. In Inhibitors of Monoamine Oxidase B. Pharmacology and Clinical Use in Neurodegenerative Disorders (Ed. I. Szelenyi), Birkhäuser, Basel, pp. 26-50.
5. P. Jenner (1991). Oxidative stess as a cause of Parkinson's disease. Acta Neurologica Scandinavica, 136(Suppl.), 6-15.
6. K.W. Lange, M.B.H. Youdim and P. Riederer (1992). Neurotoxicity and neuroprotection in Parkinson's disease. Journal of Neural Transmission, 38(Suppl.), 27-44.
7. E. Sofic, P. Riederer, H. Heinsen, H. Bechmann, G.P. Reynolds, G. Hebenstreit and M.B.H. Youdim (1988). Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. Journal of Neural Transmission, 74, 199-205.
8. B. Halliwell and J. Gutteridge (1985). Oxygen radicals and the nervous system. Trends in Neuroscience, 8, 22-29.
9. C.W. Olanow (1990). Oxidation reactions in Parkinson's disease. Neurology, 40, 32-37.
10. J. Galazka-Friedman, E.R. Bauminger, A. Friedman, M. Barcikowska, D. Hechel and I. Nowik (1996). Iron in parkinsonian and control substantia nigra: a Mössbauer spectroscopy study. Movement Disorders 11, 8-16.
11. E. Sofic, W. Paulus, K. Jellinger, P. Riederer and M.B.H. Youdim (1991). Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. Journal of Neurochemistry, 56, 978-982.
12. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynolds, K. Jellinger and M.B.H. Youdim (1989). Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. Journal of Neurochemistry, 52, 515-520.
13. P.F. Good, C.W. Olanow and O.P. Perl (1992). Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Research, 593, 343-346.
14. H. Mochizuki, H. Imai, K. Endo, K. Yokomizo, Y. Murata, N. Hattori and Y. Mizuno (1994). Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neuroscience Letters, 168, 251-253.
15. J.A. Temlett, J.P. Landsberg, F. Watt and G.W. Grime (1994). Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian african green monkey: evidence from proton microprobe elemental microanalysis. Journal of Neurochemistry, 62, 134-146.
16. E. Oestreicher, G.J. Sengstock, P. Riederer, C.W. Olanow, A.J. Dunn and G.W. Arendash (1994). Degeneration of nigrostriatal dopaminergic neurones increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Research, 660, 8-18.
17. Y. He, P.S.P. Thong, T. Lee, S.K. Leong, C.Y. Shi, P.T.H, Wong, S.Y. Yuan and F. Watt (1996). Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study. Brain Research, 735, 149-153.
18. D. Ben-Shachar and M.B.H. Youdim (1991). Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats. Journal of Neurochemistry, 57, 2133-2135.
19. G.W. Sengstock, C.W. Olanow, R.A. Menzies, A.J. Dunn and G.W. Arendash (1993). Infusion of iron into the rat substantia nigra: nigral pathology and dose dependent loss of dopaminergic markers. Journal of Neuroscience Research, 35, 67-82.
20. B.A. Faucheux, N. Nillesse, P. Damier, G. Spik, A. Pierce, B. Leveugle, N. Kubis, J.J. Hauw, Y. Agid and E.C. Hirsch (1995). Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson's disease. Proceedings of the National Academy of Science of the United States, 92, 9603-9607.
21. B. Leveugle, B.A. Faucheux, C. Bouras, N. Nillesse, G. Spk, E.C. Hirsch, Y. Agid and P.R. Hof (1996). Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathology, 91, 566-572.
22. P. Aisen (1992). Entry of iron into cells: A new role for the transferrin receptor in modulating iron release from transferrin. Annals Neurology, 32, S62-S68.
23. J.R. Connor, B.S. Snyder, J.L. Beard, R.E. Fine and E.J. Mufson (1992). The regional distribution of iron and iron regulatory proteins in the brain in aging and Alzheimer's disease. Journal of Neuroscience Research, 31, 327-335.
24. E.C. Theil (1987). Ferrintin: structure, gene regulation, and cellular function in animals, plants and microorganisms. Annual Review of Biochemistry, 56, 289-315.
25. T.C. Iancu (1992). Ferritin and hemosiderin in pathological tissures. Electron Microscopy Review, 5, 209-229.
26. D. Boyd, C. Vecoli, D.M. Belcher, S.K. Jain and J.W. Drysdale (1985). Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. Journal of Biological Chemistry, 260, 11755-11761.
27. G. Paxinos and C. Watson (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
28. J.R. Connor, S.L. Menzies, S.L. St. Martin and E.J. Mufson (1990). Cellular distribution of transferrin, ferritin and iron in normal and aged human brains. Journal of Neuroscience Research, 27, 595-611.
29. J.M. Hill, R.C. Switzer (1984). The regional distribution and cellular localisation of iron in the rat brain. Neuroscience, 11, 595-603.
30. S.M. Levine and W.B. Machlin (1990). Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. Journal of Neuroscience Research, 26, 508-512.
31. A.H. Koeppen (1995). The history of iron in the brain. Journal of Neurological Science, 134(s), 1-9.
32. R.J. Uitti, A.H. Rajput, B. Rozdilsky, M. Bickis, T. Wollin and W.K. Yuen (1989). Regional metal concentrations in Parkinson's disease, other chronic neurological disease, and control brains. Canadian Journal of Neurological Science, 16, 310-314.
33. J.R. Connor, K. Boeshore, S.A. Benkovic and S.L. Menzies (1994). Isoforms of ferritin have a specific cellular distribution in the brain. Journal of Neuroscience Research, 37, 461-465.
34. B. Leveugle, G. Spik, D.P. Perl, C. Bouras, H.M. Fillit and P.R. Hof (1994). The iron binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Research, 650, 20-31.
35. B. Bloch, T. Popocici, M.J. Levin, D. Tuil and A. Kahn (1985). Transferrin gene expression visualized in oligodendrocytes of the rat brain using in situ hybridization and immunohistochemistry. Proceedings of the National Academy of Science of the United States, 82, 6706-6710.
36. C.M. Morris, J.M. Candy, C.A. Bloxham and J.A. Edwardson (1992). Immunocytochemical localisation of transferrin in the human brain. Acta Anatomy, 143, 14-18.
37. G.J. van-Kamp, K. Mulder, M. Kuiper and E.C. Wolters (1995). Changed transferrin sialylation in Parkinson's disease. Clinica Chimica Acta, 235, 159-167.
38. F. Cabrera-Valdivia, F.J. Jimenez-Jimenez, J.A. Molina, P. Fernandez-Calle, A. Vazquen, F. Canizares-Liebana, S. Laurmbe-Bobalde, L. Ayuso-Peralta, M. Rabasa and R. Codoceo (1994). Peripheral iron metabolism in patients with Parkinson's disease. Journal of Neurological Science, 125, 82-86.
39. D.A. Loeffler, J.R. Connor, P.L. Juneau, B.S. Snyder, L. Kanaley, A.J. DeMaggio, H. Nguyen, C.M. Brickman and P.A. LeWitt (1995). Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. Journal of Neurochemistry, 65, 710-716.
40. D.T. Dexter, C.J. Carter, M. Bidailhet, M. Rubert, F. Agid, Y. Agid, A.J. Lees, F.R. Wells, P. Jenner and C.D. Marsden (1990). Decreased ferrintin levels in brain in Parkinson's disease. Journal of Neurochemistry, 55, 16-20.
41. K. Pantopoulos, G. Weiss and M.W. Hentze (1994). Nitric oxide activates iron regulatory factor and affects the posttranscriptional control of cellular iron metabolism. In The biology of Nitric Oxide. (Eds. S. Moncada, M. Feelisch, R. Busse and E.A. Higgs), Portland Press, London, pp. 24-31.
42. K. Jellinger, W. Paulus, I. Grundke-Iqbal, P. Riederer and M.B.H. Youdim (1990). Brain iron and ferritin in Parkinson's and Alzheimer's diseases. Journal of Neural Transmission - Parkinsons Disease and Dementia Section, 2, 327-340.
43. J.R. Connor, B.S. Snyder, P. Arosio, D.A. Loeffler and P. LeWitt (1995). A quantitative analysis of isoferritins in select regions of aged, Parkinsonian, and Alzheimer's disease brains. Journal of Neurochemistry, 65, 717-724.
44. K. Goto, H. Mochizuki, H. Imai, H. Akiyama and Y. Mizuno (1996). An immunohistochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Brain Research, 724, 125-128.
45. T. Youshida, M. Tanaka, A. Sotomatsu and S. Hirai (1995). Activated microglia cause superoxide-mediated release of iron from ferritin. Neuroscience Letters, 190, 21-24.